$KERX Recent News Nasdaq extends break to less-charted

New Post Public Reply Private Reply Replies (0) Message Board

Dec 6, 2013 at 12:52 PM

$KERX Recent News

Nasdaq extends break to less-charted territory 11:42 a.m. Dec. 2, 2013 - Michael Ashbaugh
6 movers to watch 2:08 p.m. Nov. 6, 2013 - The Trading Deck
Keryx climbs after treatment shows positive result 10:01 a.m. Nov. 5, 2013 - MarketWatch.com
Six stocks to watch for some upside 2:21 p.m. April 11, 2013 - The Trading Deck
6 gut checks before the stock market's opening bell 6:47 a.m. March 7, 2013 - Shawn Langlois
Towerstream, Vanguard and others price offerings 10:32 a.m. Jan. 31, 2013 - MarketWatch.com
6 gut checks before the stock market's opening bell 6:52 a.m. Jan. 31, 2013 - Shawn Langlois
Keryx Biopharmaceuticals up 8.5% in premarket 7:58 a.m. Jan. 29, 2013 - Steve Gelsi
Monday’s movers: Herbalife clobbered on FTC news 4:30 p.m. Jan. 28, 2013 - Sue Chang
In focus: No letup by the bulls 7:45 p.m. Jan. 23, 2013 - Lawrence G. McMillan
Keryx Biopharma rises 17% in premarket trades 7:36 a.m. Jan. 23, 2013 - Steve Gelsi
Monday’s biggest gaining and declining stocks 3:37 p.m. April 23, 2012 - MarketWatch
Monday’s biggest gaining & declining stocks 4:56 p.m. April 2, 2012 - Kate Gibson
Keryx, AEterna implode on failed drug study 10:13 a.m. April 2, 2012 - Val Brickates Kennedy
Keryx, AEterna rally ahead of study results 12:34 p.m. March 16, 2012 - Val Brickates Kennedy
Keryx , AEterna rally ahead of study results 12:32 p.m. March 16, 2012 - Val Brickates Kennedy
Top longs and shorts to watch 12:18 p.m. March 6, 2012 - The Trading Deck
AEterna, Keryx soar on study speculation 12:52 p.m. March 5, 2012 - Val Brickates Kennedy
Keryx Biopharmaceuticals Inc. shares gain 9.6% 9:35 a.m. Nov. 30, 2010 - Kate Gibson
Powerful uptrend meets major resistance 9:28 a.m. Oct. 25, 2010 - Michael Ashbaugh

Biotech Stock Mailbag: Enteromedics, ARCA Biopharma, Keryx Pharma 6:00 a.m. Today - TheStreet.com
Zerenex- The New Spark For Keryx? 7:42 a.m. Nov. 25, 2013 - Seeking Alpha
Commit To Buy Keryx Biopharmaceuticals At $8, Earn 28.1% Using Options 1:29 p.m. Nov. 19, 2013 - TheStreet.com
Why Doctors, Dialysis Providers And Investors Are Excited About Zerenex 10:12 a.m. Nov. 11, 2013 - Seeking Alpha
Key Issues Surrounding The Zalicus Catalyst Trade 8:56 a.m. Nov. 8, 2013 - Seeking Alpha
Keryx Biopharma Issues Update from Ongoing Zerenex LT Safety Extension Study 7:33 a.m. Nov. 8, 2013 - benzinga.com
Keryx Should Continue To Climb 5:04 a.m. Nov. 8, 2013 - Seeking Alpha
Biotech Stock Mailbag: Galectin, Keryx, Navidea, Cytori 6:10 p.m. Nov. 7, 2013 - TheStreet.com
Perilous Reversal Stock: Keryx Biopharmaceuticals (KERX) 10:29 a.m. Nov. 7, 2013 - TheStreet.com
UPDATE: J.P. Morgan Reiterates on Keryx Biopharmaceuticals on Model Update After Positive NDD-CKD Data 9:12 a.m. Nov. 7, 2013 - benzinga.com
Keryx Biopharmaceuticals' CEO Discusses Q3 2013 Results - Earnings Call Transcript 1:48 a.m. Nov. 6, 2013 - Seeking Alpha
Data Support Keryx's Anemia Drug In A New And Large Market 1:43 p.m. Nov. 5, 2013 - Seeking Alpha
Four Big Healthy Biotech Gainers, One Big Loser 1:07 p.m. Nov. 5, 2013 - 247WallSt.com
Keryx Biopharmaceuticals Announces Zerenex(TM) (ferric citrate coordination complex) Meets All Primary and Key Secondary Endpoints in Phase 2 Study 6:36 a.m. Nov. 5, 2013 - benzinga.com
10-Q: KERYX BIOPHARMACEUTICALS INC 5:05 p.m. Nov. 4, 2013 - Edgar Online - (EDG = 10Q, 10K)
UPDATE: JMP Securities Reiterates on Keryx Biopharmaceuticals on Blockbuster Potential Growing for Zerenex 8:17 a.m. Nov. 4, 2013 - benzinga.com
A Look Back At Biotech Short Picks 2:18 p.m. Oct. 31, 2013 - Seeking Alpha
4 Biotech Stocks Making Headlines 10:25 a.m. Oct. 28, 2013 - Wall St. Cheat Sheet
Sunshine Heart's Pulse System Could Revolutionize How Heart Failure Is Treated 8:59 a.m. Oct. 21, 2013 - Seeking Alpha
Trade-Ideas: Keryx Biopharmaceuticals (KERX) Is Today's "Perilous Reversal" Stock 10:44 a.m. Oct. 18, 2013 - TheStreet.com

Stock Initiation of the Day: Keryx Biopharma, GlaxoSmithKline, AstraZeneca, and Raptor Pharma 10:48 a.m. Today - PR Newswire
Regulatory Approval, Requisite Consents and Expiration of Consent Solicitations, and Stock Price Movements - Research Report on Thermo Fisher, Endo, Perrigo, Keryx, and Waters 8:00 a.m. Dec. 4, 2013 - PR Newswire
Bullish Trend Analysis: Tesla Motors Inc, XOMA Corp, Keryx Biopharmaceuticals, Oncomed Pharmaceuticals 9:01 a.m. Dec. 3, 2013 - ACCESSWIRE
Grants and Stock Movements of Major Drug Manufacturers - Research Report on AbbVie, Keryx Biopharmaceuticals, Pacira Pharmaceuticals, Rockwell Medical, and Impax Laboratories 8:00 a.m. Nov. 22, 2013 - PR Newswire
Extension Study Data, Financial Results, Scheduled Conferences and Presentations - Research Report on Keryx, Raptor, Pacira, Horizon Pharma, and Impax 8:00 a.m. Nov. 13, 2013 - PR Newswire
Morning Research: GlaxoSmithKline PLC, Keryx Biopharma Inc., AstraZeneca PLC, and Raptor Pharma Corp. 8:00 a.m. Nov. 11, 2013 - PR Newswire
IPO, Earnings & Corporate Developments: Twitter, Vale SA, OCZ Technology Group, Radian Group, Keryx Biopharmaceuticals 8:46 a.m. Nov. 8, 2013 - PR Newswire
Keryx Biopharmaceuticals Provides Update From Ongoing Zerenex(TM) (ferric citrate coordination complex) Long-Term Safety Extension Study in Patients With Hyperphosphatemia on Dialysis 8:30 a.m. Nov. 8, 2013 - GlobeNewswire
Legal Settlements, Stock Price Updates, Financial Results, and Commencement of Clinical Studies - Research Report on Johnson & Johnson, Elan, Tenet, Opko and Keryx Biopharmaceuticals 8:00 a.m. Nov. 7, 2013 - PR Newswire
M&A, Earnings and News Round Up: Keryx Biopharmaceuticals, Pandora Media, Marvell Technology Group, Starbucks, Cell Therapeutics 8:46 a.m. Nov. 6, 2013 - PR Newswire
Keryx Biopharmaceuticals to Hold Conference Call Tomorrow, November 5, 2013, at 8:30AM ET to Discuss Top-Line Results from Zerenex(TM) Phase 2 Study of Non-Dialysis Dependent Chronic Kidney Disease Patients with Elevated Serum Phosphorus and Iron Deficiency Anemia 5:00 p.m. Nov. 4, 2013 - GlobeNewswire
Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2013 Financial Results 4:30 p.m. Nov. 4, 2013 - GlobeNewswire
Quarterly Reports, License Applications, and Abstract Presentations - Research on Elan, NPS, ICON, Keryx, and Healthways 9:00 a.m. Oct. 29, 2013 - PR Newswire
Keryx Biopharmaceuticals Announces PDUFA Goal Date for Zerenex(TM) New Drug Application 8:30 a.m. Oct. 21, 2013 - GlobeNewswire
Financial Results, Quarterly Earnings Schedules, Marketing Authorizations, Completed Acquisitions, and New Drug Applications - Research Report on Johnson & Johnson, AbbVie, GSK, AstraZeneca, and Keryx 8:00 a.m. Oct. 18, 2013 - PR Newswire
Technical Study: AstraZeneca PLC, GlaxoSmithKline PLC, Keryx Biopharma Inc., and Raptor Pharma Corp. 12:51 p.m. Oct. 17, 2013 - PR Newswire
Critical Alerts For Goldman Sachs, Netflix, Nasdaq, Aetna, and Keryx Biopharmaceuticals Released By InvestorsObserver 9:31 a.m. Oct. 17, 2013 - PR Newswire
Keryx Biopharmaceuticals' Zerenex(TM) (Ferric Citrate Coordination Complex) Data Selected for Oral and Poster Presentations at the American Society of Nephrology's Kidney Week 2013 8:31 a.m. Oct. 17, 2013 - GlobeNewswire
Drug Approvals, Data Presentations, Clinical Trials, New Appointments, and Corporate Events - Research Report on Johnson & Johnson, Novo Nordisk, Isis, Keryx, and The Medicines Company 8:00 a.m. Oct. 9, 2013 - PR Newswire
Keryx Biopharmaceuticals Announces FDA Acceptance for Filing of Zerenex(TM) New Drug Application 8:30 a.m. Oct. 8, 2013 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innventure Faces Major Lawsuit Amidst Market Turmoil

The Plot Thickens with Innventure's DarkNX Project Buckle up, fellow market sling-riders; the Innventure tale is a rocky one for the books. Imagine this: You’ve plunked down your hard-earned cash on Innventure Inc. (NASDAQ: INV), lured by their glowing pronouncements about a supposed golden egg project, the Accelsius DarkNX data-center deal. A big talk about...

BrightPlan's AI-Powered Growth: Series C Fuel

Series C Funding Ignites BrightPlan's Ambitions Ever seen a company that's ready to roll with the punches and come out stronger? That's BrightPlan for you. They're pushing the boundaries again, bagging new capital in this Series C round, steered by the seasoned folks over at ABS Capital Partners. Now, here's the thing: We're talking about a 230% revenue surge over just...

AllyGPO Shines as Top Innovator in Health Tech

Innovative Excellence in Healthcare Tech It's not every day you see a specialty group purchasing organization like AllyGPO snagging a spot on Fast Company's esteemed list of Best Workplaces for Innovators. Making it into the top half at number 40 in 2026, it’s a testament to a company really leaning into employee-driven innovation. And, buddy, this ain't just corporate...

Hanover Unveils Skinny Veg® for GLP-1 Dieters

Seems like Hanover Foods is turning heads with their move into the ever-demanding health-conscious market. This family's stepping into the limelight with their new Skinny Veg® line, clearly targeting folks riding the GLP-1 wave. You see, it's not every day that a company that's been around the block since 1924 shakes things up like this. Simplicity is the Name of the...

Goodwill's ReThink Fashion: Textiles to Runway Art

Transforming Old to New on the Runway Right when you think fashion's all about the next shiny thing, here comes Goodwill of Delaware & Delaware County flipping the script. Their ReThink Fashion Show - the ECO Edit teaches us a thing or two about what giving old clothes a new life truly means. It's not just about tossing a used tee onto a catwalk but a whole rebirth...

Leidos' Autonomous Vessels Chart Bold Naval Waters

Leidos' Autonomous Leap with the U.S. Navy Well, today it's all about Leidos, an outfit that's been showing its grit in the world of maritime autonomy. Their systems aren't just tinkering around anymore—they're slicing through the waves at RIMPAC, the Rim of the Pacific, and running alongside the USS Theodore Roosevelt Carrier Strike Group. That's big news in anyone's...

The Austin Company to Showcase at ISPE Annual Event

Setting the Stage at ISPE Expo When you think of pharmaceuticals and the bustle behind closed doors, it's with companies like The Austin Company leading the charge. This October, they're strutting their stuff at the ISPE Annual Meeting and Expo. No small potatoes here—it's at the Gaylord National in Maryland. Mark those dates: October 18-21, 2026. It's a circus of...

India's First Upright Proton Therapy System Unveiled

A Leap Forward in Cancer Care: Proton Therapy Revolution Dang, just when you think you've heard it all in cancer treatment, Fortis Healthcare drops a bombshell: India’s first upright proton therapy system. Boom! This isn't your run-of-the-mill radiation treatment we're talking about here. This is the futuristic flair of the MEVION S250-FIT™, featuring upright...

Nashville Benefit Concert Supports Animal Rescue Mission

Country Tunes and Compassion Unite for Rescue Efforts There's something electric about a community banding together, especially when it's through the warmth of country music and the noble mission of animal rescue. Animal Rescue Corps (ARC), meeting ground for art and heart, is turning the Nashville Palace into a sanctuary not just for music, but for hope. They've got...

Life Flower Celebrates 16 Years with Dog Adoption Event

A Celebration with Heart Ah, the classic mix of business and community goodwill—that's what Life Flower Dispensary is all about this year. You know, not every business that hits the 16-year mark decides to make it about something bigger than just slashing prices or hyping themselves up. But Life Flower? They're using their anniversary to throw a shindig that's more than...